You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NRAS

Showing 1 - 25 of 215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

Not yet recruiting
  • Melanoma
  • tunlametinib
  • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 15, 2023

Advanced Solid Tumors Trial in Cincinnati, Houston, Salt Lake City (YL-17231)

Not yet recruiting
  • Advanced Solid Tumors
  • Cincinnati, Ohio
  • +2 more
Oct 22, 2023

Solid Tumors, KRAS Mutation Trial in Chiba, Kashiwa, Tokyo, Chuo-ku, Tokyo, Koto-ku (BI 3011441)

Completed
  • Solid Tumors, KRAS Mutation
  • BI 3011441
  • Chiba, Kashiwa, Japan
  • +2 more
Nov 11, 2022

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

Melanoma Trial in Beijing (HL-085)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
  • +1 more
Jan 19, 2022

NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors Trial in Belgium, Netherlands, United Kingdom (LNP3794)

Active, not recruiting
  • NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors
  • Brussels, Belgium
  • +3 more
Dec 24, 2021

Melanoma Trial in Beijing, Shanghai (HL-085)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
  • +1 more
Dec 16, 2021

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • TG01
  • Oslo, Norway
    Oslo Myeloma Center
May 2, 2023

Metastatic Colorectal Cancer Trial in Beijing (CPGJ602, cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Aug 16, 2021

Colon Cancer Trial in United States (Panitumumab, Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Colon Cancer
  • Tampa, Florida
  • +4 more
Nov 10, 2021

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer Trial (Cetuximab combind mFOLFOX6/FOLFIRI)

Completed
  • Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
  • Cetuximab combind mFOLFOX6/FOLFIRI
  • (no location specified)
Jan 17, 2021

Melanoma Trial in Worldwide (Belvarafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Melanoma
  • Orange, California
  • +23 more
Aug 24, 2022

Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Ann Arbor, Michigan
  • +10 more
Dec 2, 2022

OPTImal PALliative Anti-epidermal Growth Factor Receptor

Active, not recruiting
  • Colorectal Cancer Metastatic
  • +5 more
  • Plasma circulating DNA analysis
  • Aarhus, Denmark
    Aarhus University Hospital
Feb 24, 2022

Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)

Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

BRAF or NRAS Mutant Metastatic Melanoma Trial in Worldwide (MEK162)

Active, not recruiting
Has Results
  • BRAF or NRAS Mutant Metastatic Melanoma
  • Fayetteville, Arkansas
  • +20 more
Nov 18, 2021

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +1 more
Nov 8, 2022

Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,

Active, not recruiting
  • Recurrent Rectal Cancer
  • +6 more
  • Saint Louis, Missouri
  • +3 more
Feb 15, 2022

Melanoma Trial in New York, Philadelphia (Trametinib daily Until PD, CDX-3379 (ERBB3 antibody))

Terminated
Has Results
  • Melanoma
  • Trametinib daily Until PD
  • CDX-3379 (ERBB3 antibody)
  • New York, New York
  • +1 more
May 12, 2020